Suppr超能文献

致幻性医源性结构性解离:关于致幻剂使用中解离风险的探索性假设。

Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use.

作者信息

Elfrink Steven, Bergin Leigh

机构信息

OmTerra, Oregon, OR, United States.

Department of Psychology, University of Exeter, Exeter, United Kingdom.

出版信息

Front Psychol. 2025 Mar 4;16:1528253. doi: 10.3389/fpsyg.2025.1528253. eCollection 2025.

Abstract

This paper introduces the hypothesis of Psychedelic Iatrogenic Structural Dissociation (PISD), proposing that psychedelics may reactivate dissociated traumatic material, increasing the risk of psychological destabilization in trauma-exposed individuals. Grounded in structural dissociation theory, this framework suggests that psychedelics can disrupt the balance between daily functioning (the Apparently Normal Personality, ANP) and trauma-related responses (the Emotional Personality, EP), leading to the resurfacing of unintegrated memories. A review of recent studies highlights persistent adverse effects associated with psychedelic use, including emotional dysregulation, identity fragmentation, derealization, and perceptual disturbances, particularly among individuals with early trauma histories. To mitigate these risks and facilitate trauma processing, integration practices, body-focused therapies, and structured social support systems are proposed as key interventions. Additionally, emerging neurophysiological models suggest that psychedelics may reconfigure dissociative processes through the modulation of entrenched patterns, potentially facilitating trauma integration or increasing vulnerability to destabilization, depending on individual and contextual factors. These findings underscore the necessity of trauma-informed screening, preparation, and integration protocols to enhance the safety and efficacy of psychedelic therapies, particularly for vulnerable populations.

摘要

本文介绍了致幻剂医源性结构解离(PISD)假说,提出致幻剂可能会重新激活解离的创伤性材料,增加受过创伤的个体心理不稳定的风险。基于结构解离理论,该框架表明致幻剂会破坏日常功能(表面正常人格,ANP)和创伤相关反应(情感人格,EP)之间的平衡,导致未整合记忆的重新浮现。对近期研究的回顾突出了与使用致幻剂相关的持续不良影响,包括情绪失调、身份认同破碎、现实解体和感知障碍,尤其是在有早期创伤史的个体中。为了减轻这些风险并促进创伤处理,建议将整合实践、身体聚焦疗法和结构化社会支持系统作为关键干预措施。此外,新兴的神经生理学模型表明,致幻剂可能通过调节根深蒂固的模式来重新配置解离过程,这可能会促进创伤整合,也可能会根据个体和情境因素增加不稳定的易感性。这些发现强调了采用创伤知情筛查、准备和整合方案的必要性,以提高致幻剂疗法的安全性和有效性,特别是对于弱势群体。

相似文献

1
Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use.
Front Psychol. 2025 Mar 4;16:1528253. doi: 10.3389/fpsyg.2025.1528253. eCollection 2025.
2
Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):19-30. doi: 10.1089/psymed.2024.0027. eCollection 2025 Mar.
3
[Dissociative disorders: from Janet to DSM-IV].
Seishin Shinkeigaku Zasshi. 2000;102(1):1-12.
4
Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.
Chronic Stress (Thousand Oaks). 2021 Jul 11;5:24705470211029881. doi: 10.1177/24705470211029881. eCollection 2021 Jan-Dec.
5
Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach.
Front Psychiatry. 2025 Apr 2;16:1529427. doi: 10.3389/fpsyt.2025.1529427. eCollection 2025.
7
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
9
Dissociation in patients with dissociative seizures: relationships with trauma and seizure symptoms.
Psychol Med. 2017 May;47(7):1215-1229. doi: 10.1017/S0033291716003093. Epub 2017 Jan 9.
10
The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.
Front Pharmacol. 2021 Feb 23;12:619890. doi: 10.3389/fphar.2021.619890. eCollection 2021.

本文引用的文献

1
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):1-9. doi: 10.1089/psymed.2023.0036. eCollection 2024 Mar.
4
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.
Npj Ment Health Res. 2024 Jul 2;3(1):33. doi: 10.1038/s44184-024-00068-9.
6
Psychiatric risks for worsened mental health after psychedelic use.
J Psychopharmacol. 2024 Mar;38(3):225-235. doi: 10.1177/02698811241232548. Epub 2024 Mar 4.
7
Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.
J Affect Disord. 2024 Apr 15;351:194-201. doi: 10.1016/j.jad.2024.01.197. Epub 2024 Jan 26.
8
Extended difficulties following the use of psychedelic drugs: A mixed methods study.
PLoS One. 2023 Oct 24;18(10):e0293349. doi: 10.1371/journal.pone.0293349. eCollection 2023.
9
Case analysis of long-term negative psychological responses to psychedelics.
Sci Rep. 2023 Sep 25;13(1):15998. doi: 10.1038/s41598-023-41145-x.
10
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验